Search for Clinical Trial Results
Neurilemmoma - 25 Studies Found
Status | Study |
Terminated |
Study Name: A Study of Nilotinib in Growing Vestibular Schwannomas Condition: Growing Vestibular Schwannomas Date: 2010-09-13 Interventions: Drug: Nilotinib |
Completed |
Study Name: Vertigo Perception and Quality of Life in Patients After Surgical Treatment of Vestibular Schwannoma Condition: Vestibular Schwannoma Date: 2016-11-01 Interventions: Drug: gentamicin intratympanic application of gentamicin 2m/80mg - 3x application -0,5 ml |
Recruiting |
Study Name: Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma Condition:
Date: 2010-09-09 Interventions: Radiation: Fractionated proton radiation Given daily for approximately 5.5 weeks |
Recruiting |
Study Name: Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas Condition:
Date: 2014-04-29 Interventions: Drug: Axitinib Other Name: Inlyta |
Active, not recruiting |
Study Name: Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas Condition:
Interventions: Drug: Bevacizumab Treatment will be administered on an out |
Completed |
Study Name: Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2) Condition:
Date: 2010-09-01 Interventions:
|
Not yet recruiting |
Study Name: Study of Aspirin in Patients With Vestibular Schwannoma Condition:
|
Recruiting |
Study Name: Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas Condition:
Interventions: Drug: RAD001 Other Name: Everolimus |
Recruiting |
Study Name: Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma Condition:
|